Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD : A Pragmatic Multicentre Randomised Placebo Controlled Trial
Citation
Price , D B , Cotton , S , Fielding , S , McMeekin , N , Barnes , P , Briggs , A , Burns , G , Chaudhuri , R , Chrystyn , H , Davies , L , De Soyza , A , Gompertz , S , Haughney , J , Lee , A , Morice , A , Norrie , J , Sullivan , A , Wilson , A & Devereux , G 2018 , ' Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD : A Pragmatic Multicentre Randomised Placebo Controlled Trial ' , American Journal of Respiratory and Critical Care Medicine , vol. 197 , A7709 . < https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A7709 >
Rights
Originally Published in: D.B. Price, S. Cotton, S. Fielding, N. McMeekin, P. Barnes, A. Briggs, G. Burns, R. Chaudhuri, H. Chrystyn, L. Davies, A. De Soyza, S. Gompertz, J. Haughney, A. Lee, A. Morice, J. Norrie, A. Sullivan, A. Wilson, and G. Devereux. Use of 'Low-Dose' Theophylline to Reduce Exacerbations of COPD: A Pragmatic Multicentre Randomised Placebo Controlled Trial. B14. LATE BREAKING CLINICAL TRIALS AND FIRST REPORTS IN ASTHMA AND COPD. May 1, 2018, A7709-A7709. Copyright © 2017 by the American Thoracic Society The final publication is available at https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A7709.